The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1063
ISSUE1063
October 8, 1999
Two Neuraminidase Inhibitors for Treatment of Influenza
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Two Neuraminidase Inhibitors for Treatment of Influenza
October 8, 1999 (Issue: 1063)
Zanamivir, a neuraminidase inhibitor taken by inhalation, has been approved by the FDA for treatment of influenza. Oseltamivir phosphate, an oral neuraminidase inhibitor, will probably be approved soon.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.